Related Experiment Video
Updated: May 24, 2025
08:25
Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients
Published on: September 9, 2020
10.9K
Exosomes Barcoding: A smart approach for cancer liquid biopsy.
1Cancer and Stem Cell Biology Laboratory, Department of Genetic Engineering, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, 603203, India.
The Journal of Liquid Biopsy
|March 3, 2025
Summary
Tumor-derived exosomes (TEXs) show promise for early cancer detection. Advanced techniques like exosome barcoding offer new avenues for precision oncology and improved cancer screening.
Area of Science:
- Oncology
- Biochemistry
- Biotechnology
Background:
- Cancer remains a significant global health challenge.
- Early cancer detection is crucial but difficult.
- Extracellular vesicles (EVs), particularly exosomes, are emerging as key players in cancer biology.
Purpose of the Study:
- To explore the role of tumor-derived exosomes (TEXs) in cancer development and progression.
- To investigate the potential of exosomes as biomarkers for early cancer detection.
- To address the challenges posed by exosome heterogeneity in cancer liquid biopsies.
Main Methods:
- Utilizing single exosome profiling techniques.
- Implementing exosome barcoding for molecular analysis.
- Analyzing TEXs as signaling molecules in cancer.
Main Results:
- TEXs are implicated as signaling molecules in cancer progression.
- Exosome heterogeneity complicates the study of cancer liquid biopsies.
- Single exosome profiling and barcoding aid in overcoming these limitations.
Conclusions:
- Exosomes offer a novel approach for addressing the cancer crisis.
- Exosome barcoding is a promising interdisciplinary method for specific cancer screening.
- These advancements contribute significantly to the field of precision oncology.
